1-4 of 4
Søren Risom Kristensen
Close
Sort by
Journal Articles

The Risk of Venous Thromboembolism Is High in Chronic Lymphocytic Leukemia Because of Additional Cancers: A Danish National Cohort Study

Inger Lise Gade, Signe Juul Riddersholm, MD PhD, Ilse Christiansen, Christian Torp-Pedersen, MD Professor, Søren Risom Kristensen, MD Professor, Marianne Tang Severinsen, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 364.
https://doi.org/10.1182/blood-2018-99-110242
Published: 2018
Journal Articles

Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism

Irene Martínez-Martínez, José Navarro-Fernández, Alice Østergaard, Ricardo Gutiérrez-Gallego, José Padilla, Nataliya Bohdan, Antonia Miñano, Cristina Pascual, Constantino Martínez, María Eugenia de la Morena-Barrio, Sonia Águila, Shona Pedersen, Søren Risom Kristensen, Vicente Vicente, Javier Corral
Journal: Blood
Blood (2012) 120 (4): 900–904.
https://doi.org/10.1182/blood-2012-01-406207
Published: 2012
Journal Articles

Protein Inhibitor of Coagulation Factor Xa (PifXa): A New Protein-Based Specific Factor Xa Inhibitor Is An Effective, Reversible Inhibitor of Blood Coagulation.

Mette Sondrup Andersen, Aage Kristian Olsen Alstrup, Julie Kirstine Andersen, Søren Risom Kristensen, Kåre Lehmann Nielsen
Journal: Blood
Blood (2010) 116 (21): 1095.
https://doi.org/10.1182/blood.V116.21.1095.1095
Published: 2010
Journal Articles

Warfarin treatment of a patient with coagulation factor IX propeptide mutation causing warfarin hypersensitivity

Søren Risom Kristensen
Journal: Blood
Blood (2002) 100 (7): 2676.
https://doi.org/10.1182/blood-2002-06-1753
Published: 2002